site:www.fiercepharma.com

News

Regeneron scores EU nod for bispecific antibody Lynozyfic, setting up clash with J&J and Pfizer

After issues at a third-party manufacturer caused the FDA to reject Regeneron's multiple myeloma bispecific antibody ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Feedback

"%24%20is%20not%20defined","Stack":"ReferenceError%3A%20%24%20is%20not%20defined%0A%20%20%20%20at%20self%3A44%3A3529%0A%20%20%20%20at%20self%3A44%3A3535","Meta":"self","Line":"44","Char":"3529""NewsPublisherHandler%20is%20not%20defined","Stack":"ReferenceError%3A%20NewsPublisherHandler%20is%20not%20defined%0A%20%20%20%20at%20self%3A46%3A1","Meta":"self","Line":"46","Char":"1"

News

Trending now